Article Versions Notes

Ogawa L, Morinishi C, Multani A, Gaynor P, Beaird OE, Pham C, Schaenman JM. Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Viruses. 2024; 16(12):1889. https://doi.org/10.3390/v16121889

Ogawa, Lauren, Chelsea Morinishi, Ashrit Multani, Pryce Gaynor, Omer E. Beaird, Christine Pham, and Joanna M. Schaenman. 2024. "Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients" Viruses 16, no. 12: 1889. https://doi.org/10.3390/v16121889

Ogawa, L., Morinishi, C., Multani, A., Gaynor, P., Beaird, O. E., Pham, C., & Schaenman, J. M. (2024). Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Viruses, 16(12), 1889. https://doi.org/10.3390/v16121889